Sumitomo Pharma Co., Ltd. (TYO:4506)

Japan flag Japan · Delayed Price · Currency is JPY
1,811.00
+173.00 (10.56%)
Sep 5, 2025, 3:30 PM JST
10.56%
Market Cap719.49B
Revenue (ttm)416.16B
Net Income (ttm)18.90B
Shares Out397.29M
EPS (ttm)47.58
PE Ratio38.06
Forward PE10.78
Dividendn/a
Ex-Dividend Daten/a
Volume19,176,700
Average Volume7,770,850
Open1,660.00
Previous Close1,638.00
Day's Range1,647.00 - 1,819.00
52-Week Range496.00 - 1,819.00
Beta0.55
RSI82.95
Earnings DateOct 31, 2025

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in manufacture, and purchase and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia. The company offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. It also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. Further, the company offers veterinary drugs, medical devices, etc. It ha... [Read more]

Sector Healthcare
Founded 1897
Employees 3,832
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4506
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.